–
The robotics surgery company issued 2.4 million American Depositary Shares at $17.00 per ADS.
–
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at office@jewishbusinessnews.com.
Thank you.
–
Mazor Robotics Ltd. (Nasdaq: MZOR; TASE:MZOR) announced yesterday the pricing of its public offering of 2.4 million American Depositary Shares (“ADSs”) at a price of $17.00 per ADS.
The gross proceeds to the Company from the offering are expected to be $40, 800, 000 before underwriting discounts and commissions and other offering expenses. All of the ADSs in the offering are being offered by the Company. In addition, the Company has granted the underwriters a 30-day option to purchase up to 360, 000 additional ADSs at the offering price. The offering is expected to close on November 4, 2013, subject to customary closing conditions.
Barclays Capital Inc. is acting as sole book-running manager with Ladenburg Thalmann & Co. Inc., JMP Securities LLC and First Analysis Securities Corporation acting as co-managers of the offering.
Mazor Robotics’s flagship product, is Renaissan, a surgical guidance system that enables surgeons to conduct spine surgeries in an accurate and secure manner.
–
